// App-Quantinova.ai

P1035 : COUNTRY DIFFERENCES IN THE BURDEN OF PATIENTS WITH HYPEREOSINOPHILIC SYNDROME IN EUROPE

Researchers

Presenter

  • Jeremiah Hwee

Principal Investigators

  • Namhee Kwon

  • Rafael Alfonso-Cristancho

  • Lee Baylis

  • Gema Requena

  • Shawn Du

  • Anamika Khanal

  • Lynn Huynh

  • Mei Sheng Duh

  • Rupert W. Jakes

Medical Centers

  • Epidemiology,GSK,London,Royaume-uni

  • Analysis Group, Inc., Boston, MA, United States

  • Outcomes,GSK,Collegeville, PA, United States of America,United States

  • Global Medical Affairs,GSK,Durham, NC,États-unis

  • Analysis Group, Inc.,Boston,Verenigde Staten

  • Global Medical Affairs,GSK,Durham, NC,Vereinigte Staaten

  • Epidemiology,GSK,London,Storbritannien

  • Outcomes,GSK,Mississauga, ON,Kanada

  • Outcomes,GSK,Collegeville, PA, United States of America,United States

  • Epidemiology,GSK,London,Соединённое Королевство

  • Analysis Group, Inc., Boston, MA, United States

  • Development,GSK,Brentford, Middlesex,Regno Unito

  • Global Medical Affairs,GSK,Durh

  • Epidemiology,GSK,London,Vereinigtes Königreich

  • Epidemiology,GSK,London,Verenigd Koninkrijk

  • Epidemiology, LSHTM, London, United Kingdom

  • Value Evidence &

  • Development,GSK,Brentford, Middlesex,Royaume-uni

  • Epidemiology,GSK,London,Reino Unido

  • Epidemiology,GSK,London,Reino Unido

  • Global Medical Affairs,GSK,Durham, NC,Vereinigte Staaten

  • Respiratory Research &amp

  • Outcomes,GSK,Mississauga, ON,Kanada

  • Development,GSK,Brentford, Middlesex,United Kingdom

  • Outcomes,GSK,Collegeville, PA, United States of America,United States

  • Value Evidence &

  • Outcomes,GSK,Collegeville, PA, United States of America,United States

  • Global Medical Affairs,GSK,Durham, NC,Vereinigte Staaten

  • Outcomes,GSK,Mississauga, ON,Kanada

  • Global Medical Affairs,GSK,Durham, NC,États-unis

  • Analysis Group Inc.,Boston, MA,Stati Uniti

  • Analysis Group Inc.,Boston, MA,Estados Unidos

  • Analysis Group, Inc., Boston, MA

  • Analysis Group, Inc.,Boston, MA,États-unis

  • Outcomes,

  • Global Medical Affairs,GSK,Durham, NC,États-unis

  • Development,GSK,Brentford, Middlesex,Vereinigtes Königreich

  • Development,GSK,Brentford, Middlese

Locations

  • Canada

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Genetic Disorder

Disease

  • Hypereosinophilic Syndrome

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved